FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish

Matt Franks, Associate Director of Program Design at FUJIFILM Diosynth Biotechnologies (FDB), will provide an insightful update on the current and future state of FDB’s Drug Product (DP) and Finished Goods (FG) capabilities, highlighting the company’s commitment to delivering comprehensive end-to-end CDMO services. His presentation will include an overview of FDB’s integrated CDMO offerings, detailing the organization’s present and upcoming DP and FG capabilities and capacity expansions.

Additionally, Franks will share updates on FDB’s latest work and partnerships in the DP and FG space, showcasing the company’s dedication to innovation and collaboration in support of client needs.